Company
Barinthus Biotherapeutics plc. (BRNS)
Standardized SEC financial data for Barinthus Biotherapeutics plc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001828185 · NASDAQ · Pharmaceutical Preparations.
Revenue growth (YoY)
-100.0%
Return on equity
-89.4%
Free cash flow
-$48.0M
Current ratio
7.76×
EPS (diluted)
$-1.64
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $4.8M | $268K | $44.7M | $802K | $15.0M | $0 |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $43.3M | $214.1M | $194.4M | $142.1M | $112.4M | $71.9M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$11.0M | -$32.6M | -$14.4M | -$50.9M | -$28.9M | -$48.0M |
| Capital expenditures |
Get BRNS data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/BRNS/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/BRNS/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"